RxDoctor Payments Data

Anna Farnan, PA

Physician Assistant · Sherwood, ARNPI 1427814664

Payments from drug & device makers

$3,486in general payments, 2019–2025

Across 174 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$366
  • Eisai Inc.$362
  • Novartis$281
  • Lilly USA, LLC$278
  • AstraZeneca$271
  • AbbVie$265
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$3,486100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,486 in reported general payments places this provider in the 80th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$14,286
Medicare patients
113
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant15$21,850
Primidone41$1,839
Memantine Hcl ErMemantine Hcl21$1,258
Carbidopa-LevodopaCarbidopa/Levodopa31$413
Gabapentin19$398
Donepezil Hcl41$266
Topiramate28$199
Memantine Hcl17$191
Ropinirole Hcl16$164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$265$21,85015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Sherwood

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →